In addition, PD-L1 also plays protumorigenic roles in cancer cells by binding to its receptors in hematopoietic cells, which results in activation of proliferative- and survival-signaling pathways, leading to subsequent tumor progression [59]. This evidence concerns the gene CD274 and cancer.